Follow-up of Patients Referred to Unscheduled Care Centers by the Emergency Call Center in the Haut-Rhin Department, France
NCT ID: NCT05835908
Last Updated: 2025-11-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
100 participants
OBSERVATIONAL
2023-05-17
2023-06-13
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Reorientation of Tripped Patients 4 and 5 in Emergency Department
NCT05392829
Reasons for Recourse and Diagnoses Associated With Early Recourse to an Emergency Structure After Initial Treatment
NCT06194253
Development and Validation of a Regional Multi-scale System for the Prediction of the Patient Flow in the Emergencies and the Need for Hospitalization
NCT03051737
Prognosis of Geriatric Patients With Non-bedded Night in the Emergency Department: a Multicenter Cohort Study
NCT05821491
Predictive Tracking of Patient Flow in the Emergency Services During the Virus Winter Epidemics
NCT02858531
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patients who contacted the emergency call center and were referred to an unscheduled care center in the Haut-Rhin will be contacted by mail in the first instance. Ten to fifteen days after the call to the emergency call center, the investigator will contact the patient by phone, during which he/she will ask for the patient's oral consent to participate in the research and collect follow-up data using a standardized questionnaire.
If the investigator is unable to reach the patient, further attempts will be made to call the patient up to 30 days after the initial call. If there is no response after this time, patients will not be included the study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patient who contacted the Emergency Call Center and were referred to an Unscheduled Care Center
Phone questionnaire
Patients will be contacted by the investigator to collect information regarding follow-up from the initial call to the Emergency call center until the patient is taken care of in the health care facility to which he/she has been admitted.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Phone questionnaire
Patients will be contacted by the investigator to collect information regarding follow-up from the initial call to the Emergency call center until the patient is taken care of in the health care facility to which he/she has been admitted.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Referral to the Unscheduled Care Center by the Emergency Call Center
* Patient who does not answer phone within 30 days of call to the Emergency Call Center
* Patient who refuses to participate in the study
* Call for someone other than him or herself (except when a parent calls for his or her minor child)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Groupe Hospitalier de la Region de Mulhouse et Sud Alsace
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
GHRMSA
Mulhouse, Haut-Rhin, France
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GHRMSA 1290
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.